In the proposed observation, the occurrence of angioedema incidents meets the definitions of C1-INH-AAE, i.e., acquired deficiency of C1-INH, hyperactivation of the classic pathway of human complement, and recurrent angioedema symptoms. The gene discussed is SERPING1; the disease is acquired angioedema.